Daily News

View All News

Contract Watch: LiveHire signs third direct sourcing client under deal with TAPFIN

28 November 2023

LiveHire Ltd. (LVH:ASX), an Australia-based provider of direct-sourcing technology, announced today the signing of its third Statement of Work, under its Master Services Agreement with ManpowerGroup Talent Solutions (TAPFIN), with a Fortune 100 global medical device and health care company.

The end client is an existing client of TAPFIN for its Managed Service Provider services. TAPFIN is a division of ManpowerGroup and provides managed service provision to enterprise clients.

LiveHire said its total talent acquisition and direct sourcing platform has been chosen, through a competitive process, to provide its direct sourcing technology to the end client. The end client is a Fortune 100 global medical device and health care company that spends approximately USD 150 million in contingent labour, in scope for direct sourcing. The company was not named.

The SoW is for an initial term of November 2023 to January 2028 and is a binding agreement between LiveHire and TAPFIN to provide the end client with LiveHire’s direct sourcing platform and contains such other terms that are standard in agreements of this nature.

“LiveHire’s teams have worked extensively with TAPFIN’s teams and the end client, a Fortune 100 global medical device and health care company, to plan for a successful launch and scaling of their direct sourcing program. We’re thrilled to have received such a strong partnership in establishing the foundation for what will be one of the largest direct sourcing programs globally”, said Christy Forest, CEO of LiveHire.

Earlier this month, Forest offered to take only half of her current cash compensation for eight months.

On 30 June 2023, the AUD 21 million (USD 13.9 million) market-cap company posted a loss of AUD 14 million (USD 9.2 million) for its most recent financial year. Market commentators expect the company to incur a final loss in 2024 before generating positive profits in 2025.